Back to
Orbis Allan Gray Ltd
CRSP
7 quarters
Position history for
Orbis Allan Gray Ltd's holdings in CRISPR Therapeutics AG
Yes. Orbis Allan Gray holds 5,449,161 shares of CRSP (CRISPR Therapeutics), worth $297.2M, as of its Q2 2026 13F filing. It reduced the position by 656,850 shares (-10.8%) from Q1 2026. Orbis Allan Gray has held CRSP since Q4 2024, across 7 quarterly 13F filings. CRSP is 1.0% of Orbis Allan Gray's reported 13F portfolio.
Current Value
$297.2M
Current Shares
5.4M
Total Value Change
+$239.1M
Total Shares Change
+4M
Quarter-by-Quarter History
Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors